BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Imugene Limited Commences First Patient Dosing Of HER-Vaxx Phase Ib/II Gastric Cancer Study

  August 31, 2017

   · 

  3 min read
• Drug Development

  ASLAN Announces First Patient Enrolled In A Global Phase II/III Study For Varlitinib In Gastric Cancer

  August 31, 2017

   · 

  3 min read
• Business

  Simulations Plus Announces Senior Management Changes

  August 31, 2017

   · 

  4 min read
• FDA

  Teva Announces FDA Approval Of AUSTEDO (Deutetrabenazine) Tablets For The Treatment Of Tardive Dyskinesia In Adults

  August 31, 2017

   · 

  7 min read
• Drug Development

  Symphogen Presents Promising Results From A Randomized Phase II Study With Sym004 At ESMO 2017 Congress

  August 31, 2017

   · 

  2 min read
• Business

  Bone Therapeutics Announces H1 Results For 2017

  August 31, 2017

   · 

  8 min read
• Business

  Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress

  August 31, 2017

   · 

  1 min read
• Business

  Summit Therapeutics: Half-Yearly Report

  August 31, 2017

   · 

  1 min read
• Business

  MDxHealth, Inc. Announces First Half 2017 Financial Results

  August 31, 2017

   · 

  10 min read
• Biotech Beach

  Mirati Therapeutics To Participate In Immuno-Oncology Panel Discussion At The 2017 Citi Biotech Conference

  August 31, 2017

   · 

  1 min read